Loeb Points To "Mysterious" Treasury Meeting For AbbVie FailureMark Melin
Daniel Loeb feels the pain of investors anticipating the close of the the AbbVie Inc (NYSE:ABBV) / Shire PLC (ADR) (NASDAQ:SHPG) (LON:SHP) tax inversion merger as he questions a “mysterious” meeting at the Treasury Department.
Loeb on the government curbing plans for inversions
Arbitrage hedge funds with long exposure in the AbbVie Inc (NYSE:ABBV) / Shire PLC (ADR) (NASDAQ:SHPG) (LON:SHP) merger deal experienced shape pain when AbbVie “walked away from an entirely lawful deal” that Loeb infers was due to good old . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email email@example.com and we will get back to you as quick as humanly possible